{
    "SPADE_UN_18663": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18663",
            "Peptide Name": "SyCPA 4 (gladiosyn, chemically synthetic AMPs20; XXL, Lys-rich; lipopeptide; XXD3; lactam; XXJ; UCSB1a; BBW)",
            "Source": "bioinformatic predicted bacterial nonribosomal gene cluster,Burkholderia gladioliBSR3, chr 2, bacteria-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "AKSKRKGV",
            "Sequence Length": 8,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 873.06,
            "PI": 11.26,
            "Hydrophobicity": -1.43,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Chu J, Koirala B, Forelli N, Vila-Farres X, Ternei MA, Ali T, Colosimo DA, Brady SF. 2020",
                    "Reference": "J Am Chem Soc. 2020 Aug 19;142(33):14158-14168. doi: 10.1021/jacs.0c04376.PubMed",
                    "Title": "Synthetic-Bioinformatic Natural Product Antibiotics with Diverse Modes of Action."
                }
            ],
            "Frequent Amino Acids": "KAG",
            "Absent Amino Acids": "CDEFHILMNOPQTUWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 2,
            "Polar Residues": 7,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Net Charge": 4,
            "Comments": "Discovery: the peptide was predicted but made in a different way.Sequence analysis: APD analysis reveals this sequence is most similar (44.44%) toCr-ACP1Chemical modification: N-terminus coupled with tetradecanoic acid (surragate of S or T in the original sequence) to facilitate sidechain cyclization; Residues S3, R5, and V8 are D-amino acids (XXD3).Activity: active against B. subtilis 168 1A1 (MIC 8 ug/ml), E. faecium Com15 (MIC 64 ug/ml), S. aureus USA300 (MIC 64 ug/ml), E-coli DH5alpha (MIC>64 ug/ml), K-pneumoniae ATCC 10031 (MIC>64 ug/ml), A-baumannii ATCC 17978 (MIC>64 ug/ml), P-aeruginosa PAO1 (MIC>64 ug/ml), E-cloacae ATCC 14037 (MIC>64 ug/ml), M-tuberculosis H37RV (MIC>12.5 ug/ml).MOA: inhibits cell wall synthesis. Reg. 12/2021",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03890",
                    "Similarity": 1.0,
                    "Sequence": "RHFCGGALIHARFVMTAAKS"
                },
                {
                    "SPADE_ID": "SPADE_N_05111",
                    "Similarity": 1.0,
                    "Sequence": "MNVESRNSEKAWNRAIVKAEQEAAKKKMERLAKMRAKSKRK"
                },
                {
                    "SPADE_ID": "SPADE_UN_10559",
                    "Similarity": 1.0,
                    "Sequence": "ITLNNSVALDPIDISIELNKAKS"
                }
            ]
        }
    }
}